[1]
|
Zanzonico PB. Internal radionuclide radiation dosime-try:A review of basic concepts and recent develop-ments[J]. J Nucl Med, 2000, 41:297-308. |
[2]
|
Kolbert KS, Scott AM. Implementation and evaluation of patient-specific three-dimensional internal dosimetry[J]. J Nucl Med, 1997, 38:301-308. |
[3]
|
Siegel JA, Thomas SR, Stubbs JB, et al. MIRD pam-phlet No.16:Techniques for quantitative radiopharma-ceutical biodistribution data acquisition and analysis for use in human radiation dose estimates[J]. J Nucl Med, 1999, 40:37s-61s. |
[4]
|
Erdi AK, Yorke ED, Loew MH, et al. Use of the fast Hartley transform for three-dimensional dose calculation in radionuclide therapy[J]. Med Phys, 1998, 11:2226-2233. |
[5]
|
Wesley EB, Lionel GB, James SR, et al. MIRD Pamplet No.17:The dosimetry of nonuniform activity distributions-radionuclide S values at the voxel level[J]. J Nucl Med, 1999, 40:11s-36s. |
[6]
|
Michael L, Katarina S, Xiaowei L, et al. A 3-di-mensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy:Evalua-tion for 131I using Monte Carlo simulation[J]. J Nucl Med, 2002, 43:1101-1109. |
[7]
|
Kyeong MK, Andrea V, Hiroshi W, etal. Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities[J]. J Nucl Med,2003, 44:512-519. |
[8]
|
Da-Silva AJ, Tang HR, Wong KH, et al. Absolute quantification of regional myocardial uptake of 99mTc-sestamibi with SPECT:experimental validation in a porcine model[J]. J Nucl Med, 2001, 42(5):772-779. |